Transparency Market Research

Global Organ Preservation Solutions Market Is Expected to Reach USD 130 Billion in 2018: Transparency Market Research


Albany, NY -- (SBWIRE) -- 09/15/2014 -- Albany, New York, August 19, 2014 – In its latest report titled, ‘Organ Preservation Solutions Market (By Solutions - Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and Others, and By Preservation Techniques- Hypothermic Perfusion Preservation, Static Cold Storage and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019’, Transparency Market Research states that in 2012, the worldwide market for organ preservation solutions was worth $0.06 billion and will grow to $0.20 billion in 2019 at a CAGR of 16.5%.

To browse organ preservation solutions market report, please visit:

The market is largely driven by the increasing number of patients on the organ transplant list. Change in lifestyle such as alcohol consumption, smoking and fast food have led to rising incidences of organ failure, also giving rise to organ preservation solutions especially in developed countries such as the U.S. and the U.K. Other factors which have contributed to the growth of the industry include widening geriatric population, technological advancements, improving reimbursement conditions, and rise in per capita healthcare expenditure in emerging economies such as India.

In contrast, the lack of organ donors and high cost of preserving and maintaining the organs has restrained the growth of the market.

The market can be segmented on the basis of technique, solution and geography. The various solutions for organ preservation, as mentioned in the report, include Custodiol HTK (Histidine-Tryptophan-Ketoglutarate), Viaspan, Renograf, Perfadex, Hypothermosol, Lifor, siRNA Transplant Solutions, and Human bioSystem (HBS) Solution. The different techniques used to preserve organs include Static Cold Storage (SCS) and Hypothermic Perfusion Preservation (HPP). The four main regions that the global organ preservation solutions market is divided into are North America, Europe, Asia-Pacific and Rest of the World.

Of the major solutions, Custodial and Viaspan together account for more than 75% of the total market share as far as revenue is concerned. Custodial is expected to register a 17.1% CAGR during the forecast period, making it the fastest growing segment among solutions. Among techniques, the HPP segment is estimated to grow at a CAGR of 19.2% from 2013 to 2019. Europe accounted for the largest share in the total revenue in 2012, growing at a CAGR of 17.3% during the forecast period.

The global market for organ preservation solutions is led by players such as Teva Pharmaceutical Industries Ltd., Dr. Franz Köhler Chemie GmbH, BioLife Solutions, Inc., Bristol-Myers Squibb, ToleroTech, Inc., and XVIVO Perfusion AB.

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.